Icon (ICLR) Profit After Tax (2009 - 2026)
Icon's (ICLR) quarterly Profit After Tax came in at $72.6 million in Q2 2026, down 64.34% year-over-year from $203.5 million in Q2 2025, and down 30.71% quarter-over-quarter from $104.8 million in Q1 2026.
Analysis
Icon (ICLR) Profit After Tax (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Profit After Tax for 18 consecutive years, with $72.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Profit After Tax fell 64.34% year-over-year to $72.6 million in Q2 2026; TTM through Jun 2026 was $328.9 million, a 63.98% decrease from a year earlier, with the FY2025 full-year figure at $757.5 million, down 8.46% from the prior year.
- Profit After Tax was $72.6 million for Q2 2026 at Icon, down from $104.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $294.7 million in Q4 2024 and troughed at $2.4 million in Q3 2025.
- A 5-year average of $146.4 million and a median of $148.1 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 72.16% in 2024 and tumbled 98.81% in 2025, its largest moves.
- Over 5 years, Profit After Tax stood at $117.4 million in 2022, then jumped by 56.15% to $183.4 million in 2023, then soared by 60.72% to $294.7 million in 2024, then tumbled by 49.38% to $149.2 million in 2025, then tumbled by 51.35% to $72.6 million in 2026.
- The last three Profit After Tax figures came in at $72.6 million (Q2 2026), $104.8 million (Q1 2026), and $149.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 258.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 72.58 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -1.48 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -57.32 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -4.36 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.58 Mn |
| Mar 31, 2026 | 104.75 Mn |
| Dec 31, 2025 | 149.19 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 203.52 Mn |
| Mar 31, 2025 | 217.55 Mn |
| Dec 31, 2024 | 294.75 Mn |
| Sep 30, 2024 | 197.13 Mn |
| Jun 30, 2024 | 146.91 Mn |
| Mar 31, 2024 | 187.44 Mn |
| Dec 31, 2023 | 183.39 Mn |
| Sep 30, 2023 | 153.90 Mn |
| Jun 30, 2023 | 108.05 Mn |
| Mar 31, 2023 | 108.88 Mn |
| Dec 31, 2022 | 117.45 Mn |
| Sep 30, 2022 | 160.15 Mn |
| Jun 30, 2022 | 115.73 Mn |
| Mar 31, 2022 | 111.97 Mn |
| Dec 31, 2021 | 76.47 Mn |
| Sep 30, 2021 | 94.27 Mn |